Scandinavian Journal of Urology and Nephrology · 2006 · 17 citations · 13 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMedical GeneticsMolecular OncologyCancer GenomicsCancer RiskGenetic Risk AssessmentGermline Cancer SusceptibilityMalignant NeoplasmsProstate CancerFamilial Cancer RiskGenetic Predisposition To CancerGenetic Susceptibility To Prostate CancerHereditary Cancer RiskHereditary Prostate CancerInherited Cancer RiskMatched Control GroupMutation
OBJECTIVE: CHEK2*1100delC is a frame-shifting germ-line mutation which abolishes the function of cell-cycle-checkpoint kinase 2 (chk2) and hence impairs the cells' response to DNA damage. This variant occurs in 1% of the general Western population but has been reported to be more common among patients with breast and prostate cancer. The aim of this study was to investigate the significance of CHEK2*1100delC as a possible high-risk gene for hereditary prostate cancer in the population of southern Sweden. MATERIAL AND METHODS: We screened for the CHEK2*1100delC variant in 419 men diagnosed with prostate cancer in southern Sweden, 145 of whom were sporadic cases that were divided into two subgroups depending on whether they were diagnosed before (n=64) or after (n=81) the age of 55 years. A further 126 men were classified as familial prostate cancer cases and 148 as hereditary prostate cancer cases. The control group consisted of 305 military conscripts aged 18 years (range 18-21 years). RESULTS: The CHEK2*1100delC variant was found in 1.2% of the cases (sporadic: 0.7%; familial: 1.6%; hereditary: 1.4%) and in 1.0% of the controls. CONCLUSION: The CHEK2 1100delC mutation is not a clinically important high-risk gene for hereditary prostate cancer susceptibility in the population of southern Sweden.
13
Chk2/hCds1 functions as a DNA damage checkpoint in G<sub>1</sub>by stabilizing p53
Nabil Chehab, Asra Malikzay, Michael Appel et al. · Genes & Development · 2000 · 792 citations · Full text
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Jong‐Soo Lee, Kimberly M. Collins, Alexandra L. Brown et al. · Nature · 2000 · 530 citations